Sign in

CIK 0001347178 · Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
030491827
Phone
202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. S-1/A Offering Registration Statement
  6. S-1/A Offering Registration Statement
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. S-1/A Offering Registration Statement
  10. S-1/A Offering Registration Statement
  11. 8-A12G Other 8-A12G
  12. UPLOAD Other SEC-generated Letter
  13. UPLOAD Other SEC-generated Letter
  14. S-1/A Offering Registration Statement
  15. S-1/A Offering Registration Statement
  16. UPLOAD Other SEC-generated Letter
  17. S-1 Offering Registration Statement

Page 67 of 67 · 1,337 filings